RNA-based drug shows promise for lowering blood pressure
In 2023, a small preliminary study found that single injection of a new RNA-based drug may lower blood pressure for up to six months.
Content restricted. Requires subscription
In 2023, a small preliminary study found that single injection of a new RNA-based drug may lower blood pressure for up to six months.